Metastatic pancreatic endocrine carcinoma

Metastatic Pancreatic Endocrine Carcinoma

Metastatic pancreatic endocrine carcinoma is a rare form of cancer that starts in cells located within the pancreas and spreads to other parts of the body. It is a subtype of pancreatic cancer, representing less than 5% of all pancreatic cancers and less than 1% of all cancers diagnosed in the United States.

This type of cancer usually affects older adults. The average age for people with metastatic pancreatic endocrine carcinoma is 65. The median survival rate is six to 24 months, depending on the stage of the cancer and its location in the body.


At first, many people may not have any symptoms, or the symptoms may not be severe. As the cancer progresses, the symptoms may include abdominal pain, weight loss, and an enlarged liver. Other symptoms such as jaundice (yellowing of the skin and eyes), back pain, diarrhea or changes in stool color can occur.

Diagnosis and Treatment

Diagnosis of metastatic endocrine tumors may involve the following:

  • Blood tests
  • CT scan
  • MRI scan
  • Ultrasound
  • Treatment for metastatic pancreatic endocrine carcinoma is determined by the location of the cancer and the type of cancer cells. Treatment options may include radiation therapy, chemotherapy, and surgery.


    There are not specific steps to prevent metastatic endocrine cancer. However, maintaining a healthy lifestyle, which includes not smoking, exercising regularly, and eating a diet rich in fruits and vegetables, may help reduce the risk of other types of cancer.